Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Quebec Health Minister Christian Dube receives the AstraZeneca vaccine at a COVID-19 vaccination clinic in Montreal on March 18, 2021.

Paul Chiasson/The Canadian Press

Since Canada’s COVID-19 vaccination campaign began, Quebec has sometimes set aside Ottawa’s advice to forge its own path, decisions first criticized as experiments that later became mainstream.

How Quebec carved an independent vaccination plan comes from the province’s distinct public health history and autonomous political culture, relying on its own long-standing expertise and looking beyond Canada’s borders to evaluate the latest evidence.

“Quebec is very jealous of protecting its capacity to influence and regulate anything that has to do with vivre ensemble [social harmony] and culture, which writ large includes community health,” said Louise Potvin, a professor of public health at the University of Montreal. “They have a lot of expertise and research capacity, which gives them more independence. This matters a lot when you perceive yourself as a distinct society.”

Story continues below advertisement

Tracking Canada’s COVID-19 vaccine rollout plans: A continuing guide

Coronavirus tracker: How many COVID-19 cases are there in Canada and worldwide? The latest maps and charts

The province made two decisions some considered risky – delaying second doses and giving the AstraZeneca vaccine to older people – that eventually gained widespread acceptance. The machinery behind those decisions dates back decades.

In 1998 in the wake of the second failed independence referendum, the Parti Québécois government created Canada’s first provincial or federal public health research institute. The Institut national de santé publique du Québec (INSPQ) became a quasi-independent expert advisory body that has led research on everything from how to handle heatwaves in Montreal to cutting the smoking rate in half in Quebec over the past 20 years.

The INSPQ became the umbrella organization for provincial laboratories and advisory bodies such as the Quebec immunization committee, which for 30 years has told the province the best way to deliver shots. The INSPQ studies the efficacy of those and other public health decisions.

“I think it’s good to have the capacity to adapt to the reality in Quebec,” said Nicholas Brousseau, the chair of the Quebec immunization committee and a specialist in biological risk and workplace health at the INSPQ. “We are able to examine issues like frequency of illness in our own backyard when we recommend a plan.”

Quebec has been the hardest-hit province since the pandemic started, with nearly half of Canada’s 22,580 deaths but less than one-quarter of the population. Quebec also has the highest proportion of vulnerable people aged 65 and over outside Atlantic Canada.

When vaccines started arriving in December, Quebec sent most of them directly to long-term care homes rather than hospitals, as many other provinces did.

On Dec. 18, the INSPQ immunization committee recommended delaying second doses until 1.7 million Quebeckers in priority groups, mostly people 70 and over, each received a first dose. The plan ignored manufacturers’ schedules and advice from the National Advisory Committee on Immunization (NACI), which said provinces should stick to the manufacturers’ plans of 21-to-28 day delays. Half of those people have now received a first dose.

Story continues below advertisement

A month later, the province decided to delay second doses up to 90 days. The government led by Premier François Legault and Public Health Director Horacio Arruda approved the plan. By February, reports from the INSPQ and the British Columbia Centre for Disease Control (BCCDC) said the plan was working to stop serious illness and death. Other provinces adopted the delay plan, extending it up to four months. “It was an example where Quebec was innovative and other jurisdictions followed,” Dr. Brousseau said.

Early this month, Dr. Brousseau’s group went against NACI guidelines to recommend giving the AstraZeneca vaccine to people over 65. In the clinical trial, the number of adults 65 years of age and over was too small to give a reliable estimate of how well the vaccine works in this age group, but the most recent real-world studies in Britain showed it was very effective. NACI reversed itself to follow the INSPQ recommendations March 16.

“It’s normal when the science is evolving so rapidly that different organizations can reach different conclusions,” Dr. Brousseau said “It’s healthy to have these debates.”

While health is a provincial responsibility under the Constitution, Ottawa purchases and approves vaccines and has its own public health research and advisory capacity. But the provinces still have the power to decide how to give shots.

The Public Health Agency of Canada was established in 2004 after the SARS epidemic and Ontario Public Health, which has a research division, followed in 2008. The BCCDC was part of the Vancouver health board before becoming a provincial agency.

Trevor Hancock, a retired professor of public health at the University of Victoria, pointed out provinces and cities have been in charge of public health for more than 100 years. “PHAC is the new kid on the block,” he said.

Story continues below advertisement

“The beauty of having 10 different health departments in the provinces is that there’s room for diversity and experiment,” Dr. Hancock said.

While Ontario and B.C. have considerable public health research capacity, “the added element of Quebec nationalism” further separates the province from the others, Dr. Hancock said.

Mr. Legault, himself a onetime separatist who now promotes Quebec autonomy within Canada, doesn’t hesitate to chart his own path with the recommendations from the INSPQ and its vaccination committee. Still, within Quebec, the vaccine decisions were controversial, as were other INSPQ recommendations that led the government to slowly adopt mask use and decide against installing air purifiers in schools.

“Whether it be wearing masks or the timing of a second dose, it is not treating people as guinea pigs to make decisions amid uncertainty, or to change course,” Dr. Hancock said. “That’s good science. Science doesn’t mean certainty.”

Editor’s note: A previous version of this story said clinical trials for the AstraZeneca COVID-19 vaccine suggested it was less effective with older people. In fact, the clinical trial lacked data on older people.

Sign up for the Coronavirus Update newsletter to read the day’s essential coronavirus news, features and explainers written by Globe reporters and editors.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies